Adenosine-Pathway Targeted Cancer Immunotherapy
Evvnt Promotion / evvnt
Archiv
10.05.2022 - 12.05.2022 Omni Parker House, 60 School Street, 02108 Boston, USA
Time: 09:00 - 15:30
Kongressthemen
Maximize the Clinical and Commercial Opportunity of the Adenosine-Pathway as a Second-generation Immuno-oncology Target.
Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement, enthusiasm, and R and D investment for adenosine-pathway targets.
Maximize the Clinical and Commercial Opportunity of the Adenosine-Pathway as a Second-generation Immuno-oncology Target.
Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement, enthusiasm, and R and D investment for adenosine-pathway targets.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Arabella Young, Assistant Professor in the Department of Pathology; Investigator at the Huntsman Cancer Institute, The University of Utah, Bin Zhang, Professor, Northwestern University and more.
Speakers: Arabella Young, Assistant Professor in the Department of Pathology; Investigator at the Huntsman Cancer Institute, The University of Utah, Bin Zhang, Professor, Northwestern University and more.
Anfragen und Anmeldung:
https://go.evvnt.com/974505-1?pid=4832
Frau Hollie Bulfin
Onkologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
